Roche Holding saw its EPS decline at a compound rate of 6.7% per year, over the last three years. This reduction in EPS is ...

With the U.S. election result and the German government’s collapse, the lagging European economy is at a crossroads.

Sarepta Therapeutics is advancing SRP-9003 gene therapy for LGMD, with phase 3 study results expected in early 2025. Learn ...

In April 2021, Novartis AG announced a collaboration with Artios Pharma ... and Strategic Transformation. Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Digital Pathology Market. In 2023, the digital pathology market is expected to be valued at USD 7,035.8 million USD. By 2033, the market is anticipated to reach USD 24,961.8 milli ...

The Swiss People's Party (SVP) - which is the largest in the ruling coalition of four parties - launched the anti-immigration ...

Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either Roche Holding AG (RHHBY) or AbbVie (ABBV). But which of these two stocks offers value investors a ...

For some of Europe’s biggest exporters, the prospect of a stronger dollar offers a silver lining in the uncertain outlook ...

Data from two Alzheimer’s tests being developed by Roche Holding AG showed high accuracy in detecting the disease in patients being tested for the condition. The tests measure biomarkers in the blood ...

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...

Basel, 05 November 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 40 abstracts across nine blood disorders at the 66th American Society of Hematology (ASH) An ...